Clevexel

Management team

C.Bloy0

Christian has more than 30 years of experience in R&D, Manufacturing and Regulatory affairs. Before founding Clevexel Pharma, Christian was site manager and senior director of drug development for Europe at Cephalon Inc.. Prior to Cephalon, he was Senior Director of R&D in Immune Mediated Diseases and Transplant at Genzyme. He was previously on the Board of Directors of Cassenne Laboratory (Hoechst Marion Roussel group), Flamel Technology, and Genzyme Polyclonals. Christian is the author of more than 35 peer-reviewed articles and 6 patents, including one on the Central Nervous System. He holds a Ph.D. in Immuno-hematology from the Paris VI University.
Empty tab. Edit page to add content here.

XP. WANG0

Xiuping has more than 25 years of experience in Drug Development in academia and in pharmaceutical industry from early drug discovery to clinical studies. Before founding Clevexel Pharma, she was associate director at Cephalon Development Centre in charge of analytical development. In that capacity, her focus has been centered on team management and integrative leadership to ensure the interaction with other functions for effective drug development in accordance with regulatory quality standards. Xiuping graduated with a Pharmacist Diploma from Shanghai Medical College, Fudan University (China), she has concluded her Ph. D. in Pharmaceutical Sciences from University René Descartes – Paris V, France.
Empty tab. Edit page to add content here.

L.BENEL0

Laurent has more than 30 years of experience in Pharmaceutical R&D centered on management of teams and projects such as research programs, organizational changes and facility build-up, logistic and organization. Before founding Clevexel Pharma, he was associate director at Cephalon Development Centre in charge of laboratory equipment compliance. Cell biologist and pharmacologist by training, he has spent more than 18 years in discovery research at Laboratoire Lafon and Cephalon Inc. managing research programs in inflammation and oncology. He is the author of more than 15 peer-reviewed articles and publications and numerous speeches. He Contribute to the development of the Modiodal® and Provigil® psychostimulants (marketed in the US).
Laurent holds a Ph.D. in Pharmaceutical Sciences from Paris XI University.
Empty tab. Edit page to add content here.